Camden Biotechnology began operations in September 2016. The following selected transactions relate to liabilities of the company for September 2016 through March 2017. Camden's fiscal year ends on December 31. Its financial statements are issued in April 2016 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $14,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees b. On October 1, borrowed $11 million cash from Second Commercial Bank under the line of credit and issued a five-month promissory note, interest at the prime rate of 9% was payable at maturity. Management planned to issue 10-year bonds in February to repay the note chemical-based products 3% and the local sales tax rate is 3%. (This is a summary journal entry for the many individual sales c. Received $2,300 of refundable deposits in December for reusable containers used to transport and store d. For the September-December period, sales on account totaled $4,560,000. The state sales tax rate is e. Recorded the adjusting entry for accrued interest. 2017 transactions for the period.) f. In February, issued $9.5 million of 10-year bonds at face value and paid the bank loan on the March 1 due date g. Half of the storage containers covered by refundable deposits were returned in March. The remaining containers are expected to be returned during the next six months Required 1. Prepare the appropriate journal entries for 2016 and 2017 transactions. (If no entry is required for a transaction/event, select "No journal entry required" in the first account field. Enter your answers in whole dollars.)